These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 22701633)

  • 41. HLA-A2-restricted cytotoxic T lymphocyte epitopes from human heparanase as novel targets for broad-spectrum tumor immunotherapy.
    Chen T; Tang XD; Wan Y; Chen L; Yu ST; Xiong Z; Fang DC; Liang GP; Yang SM
    Neoplasia; 2008 Sep; 10(9):977-86. PubMed ID: 18714399
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protective CD8
    Ma Y; Tang K; Zhang Y; Zhang C; Cheng L; Zhang F; Zhuang R; Jin B; Zhang Y
    Virol J; 2020 Oct; 17(1):146. PubMed ID: 33028368
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [In vitro induction of immune response by dendritic cells pulsed with TRAG-3-derived cytotoxic T lymphocyte epitope].
    Zhu B; Chen ZT; Cheng XM; Wu YZ
    Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):709-12. PubMed ID: 15733385
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aspartate-β-hydroxylase induces epitope-specific T cell responses in hepatocellular carcinoma.
    Tomimaru Y; Mishra S; Safran H; Charpentier KP; Martin W; De Groot AS; Gregory SH; Wands JR
    Vaccine; 2015 Mar; 33(10):1256-66. PubMed ID: 25629522
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Melanoma-reactive class I-restricted cytotoxic T cell clones are stimulated by dendritic cells loaded with synthetic peptides, but fail to respond to dendritic cells pulsed with melanoma-derived heat shock proteins in vitro.
    Fleischer K; Schmidt B; Kastenmüller W; Busch DH; Drexler I; Sutter G; Heike M; Peschel C; Bernhard H
    J Immunol; 2004 Jan; 172(1):162-9. PubMed ID: 14688322
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of novel hepatitis C virus-specific cytotoxic T lymphocyte epitopes by ELISpot assay using peptides with human leukocyte antigen-A*2402-binding motifs.
    Hakamada T; Funatsuki K; Morita H; Ugajin T; Nakamura I; Ishiko H; Matsuzaki Y; Tanaka N; Imawari M
    J Gen Virol; 2004 Jun; 85(Pt 6):1521-1531. PubMed ID: 15166436
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lassa fever virus peptides predicted by computational analysis induce epitope-specific cytotoxic-T-lymphocyte responses in HLA-A2.1 transgenic mice.
    Boesen A; Sundar K; Coico R
    Clin Diagn Lab Immunol; 2005 Oct; 12(10):1223-30. PubMed ID: 16210487
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeting naturally occurring epitope variants of hepatitis C virus with high-affinity T-cell receptors.
    Zhang H; Zhang J; Chen L; Weng Z; Tian Y; Zhao H; Li Y; Chen L; Liang Z; Zheng H; Zhao W; Zhong S; Li Y
    J Gen Virol; 2017 Mar; 98(3):374-384. PubMed ID: 27902325
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.
    Nayersina R; Fowler P; Guilhot S; Missale G; Cerny A; Schlicht HJ; Vitiello A; Chesnut R; Person JL; Redeker AG; Chisari FV
    J Immunol; 1993 May; 150(10):4659-71. PubMed ID: 7683326
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effective induction of type 1 cytotoxic T cell responses in mice with DNA vaccine encoding two hepatitis C virus cytotoxic T lymphocyte epitopes.
    Shi L; Liu S; Fan GX; Sheng L; Ren HX; Yuan YK
    Viral Immunol; 2006; 19(4):702-11. PubMed ID: 17201665
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of HLA-A*0201-restricted CTL Epitopes for MLAA-34-specific Immunotherapy for Acute Monocytic Leukemia.
    Bai J; Wang J; Yang Y; Wang F; He A; Zhang W
    J Immunother; 2021 May; 44(4):141-150. PubMed ID: 33596023
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens.
    Urbani S; Uggeri J; Matsuura Y; Miyamura T; Penna A; Boni C; Ferrari C
    Hepatology; 2001 Jun; 33(6):1533-43. PubMed ID: 11391544
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1.
    Shirai M; Arichi T; Nishioka M; Nomura T; Ikeda K; Kawanishi K; Engelhard VH; Feinstone SM; Berzofsky JA
    J Immunol; 1995 Mar; 154(6):2733-42. PubMed ID: 7533182
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Presentation of available CTL epitopes that induction of cell-mediated immune response against HIV-1 Koran clade B strain using computational technology.
    Park H; Chung YS; Yoon CH; Lee SH; Kim SS; Kang C; Choi BS
    HIV Med; 2016 Jun; 17(6):460-6. PubMed ID: 26471354
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Immune responses of dendritic cells after loaded with cytotoxicity T lymphocyte epitope based peptide of human alpha-fetoprotein (hAFP)].
    Guo J; Cai M; Wei D; Qin L; Huang J; Wang X
    Zhonghua Gan Zang Bing Za Zhi; 2002 Jun; 10(3):178-80. PubMed ID: 12113671
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
    Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M
    Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of HLA-A2-restricted CD8(+) cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes cross-presented by dendritic cells.
    Kita H; Lian ZX; Van de Water J; He XS; Matsumura S; Kaplan M; Luketic V; Coppel RL; Ansari AA; Gershwin ME
    J Exp Med; 2002 Jan; 195(1):113-23. PubMed ID: 11781370
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of HLA-A2 restricted epitopes of glypican-3 and induction of CTL responses in HLA-A2 transgenic mice.
    Jin X; Liu X; Zhou Z; Ding Y; Wu Y; Qiu J; Shen C
    Cancer Immunol Immunother; 2022 Jul; 71(7):1569-1582. PubMed ID: 34724090
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Natural epitope variants of the hepatitis C virus impair cytotoxic T lymphocyte activity.
    Wang S; Buchli R; Schiller J; Gao J; VanGundy RS; Hildebrand WH; Eckels DD
    World J Gastroenterol; 2010 Apr; 16(16):1953-69. PubMed ID: 20419832
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunogenic variation between multiple HLA-A*0201-restricted, Hepatitis C Virus-derived epitopes for cytotoxic T lymphocytes.
    Ohno S; Moriya O; Yoshimoto T; Hayashi H; Akatsuka T; Matsui M
    Viral Immunol; 2006; 19(3):458-67. PubMed ID: 16987064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.